A clinical study to evaluate the role of proinflammatory cytokines in acute myocardial infarction

A clinical study to evaluate the role of proinflammatory cytokines in acute myocardial infarction - A clinical study on the inflammation in acute myocardial infarction

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000001022

Enrollment

150

Registered

2012-03-01

Start date

2008-02-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with first ST-elevation acute myocardial infarction, in whom time elapsed from onset to admission was within 24 hours

Exclusion criteria

Exclusion criteria: infectious disease, collagen disease, malignancy, advanced liver disease, and renal failure

Design outcomes

Primary

Measure	Time frame
in hospital and out of hospital clinical complications (pump failure, cardiac rupture, VT/VF, cardiac death)	—

Secondary

Measure	Time frame
left ventricular remodeling (echocardiography and left ventriculography) biomarker (white blood cell counts, CK, CRP, BNP, proinflammatory cytokines)	—

Countries

Japan

Contacts

Public ContactTakashi Kohno

Keio University School of Medicine, Department of Medicine Division of Cardiology

kohno.ta@gmail.com03-5363-3793

Outcome results